Philip R. Greipp

444 citations
8 papers · 324 indexed · h-index 7
Topics
Multiple Myeloma Research and Treatments (4 papers)Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers)Pancreatic and Hepatic Oncology Research (1 paper)
Partner nations
United StatesFrance

In The Last Decade

Philip R. Greipp

8 papers receiving 315 citations

Peers

Philip R. Greipp
Comparison fields: 5 of 35
  • Hematology 201
  • Molecular Biology 163
  • Oncology 117
  • Genetics 85
  • Pathology and Forensic Medicine 40
Replace JM Hernández with:
JM Hernández Spain
Roberto Sosa Hernández Spain
Jun Kuyama Japan
BA Peterson United States
Miriam Hobbs United States
Diana F. Sabath United States
Steven R. Schuster United States
AM Gewirtz United States
Fernando Escalante Spain
G. Mahl Israel
Philip R. Greipp relative to JM Hernández Spain JM Hernández's profile →
Citations per field
00.5×1.5×
JM Hernández · 1×
Citations per year

Countries citing papers authored by Philip R. Greipp

Since Specialization
Citations

This map shows the geographic impact of Philip R. Greipp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip R. Greipp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip R. Greipp more than expected).

Fields of papers citing papers by Philip R. Greipp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip R. Greipp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip R. Greipp. The network helps show where Philip R. Greipp may publish in the future.

Co-authorship network of co-authors of Philip R. Greipp

This figure shows the co-authorship network connecting the top 25 collaborators of Philip R. Greipp. A scholar is included among the top collaborators of Philip R. Greipp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip R. Greipp. Philip R. Greipp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 56
2 31
3 39
4 93
5 6
6 33
7 23
8 43

About Philip R. Greipp

Philip R. Greipp is a scholar working on Hematology, Nephrology and Oncology, having authored 8 papers that have together received 324 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Hematology (201 citations), Genetics (85 citations) and Oncology (117 citations). Philip R. Greipp has collaborated with scholars based in United States and France. Frequent co-authors include Robert A. Kyle, Curtis A. Hanson, Eric R. Christensen, Gordon W. Dewald, Syed M. Jalal, Brian Van Ness, Traci Leong, Charles H. Mckenna, Jerry A. Katzmann and Clement J. Michet. Their work appears in journals such as Annals of Internal Medicine, Cancer and The American Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026